Top Stock Picks for Income Seekers

If you're looking to boost your portfolio's income, try taking a leaf from the top U.K. equity income fund managers' books

Holly Cook 7 February, 2012 | 3:27PM
Facebook Twitter LinkedIn

Morningstar is a big exponent of the benefit of putting your eggs in many baskets by buying funds rather than individual shares, but we also recognise that many investors prefer to avoid management fees and seek to add alpha themselves. That's why we analyse and publish ratings on equities as well as funds, not to mention investment trusts and ETFs.

Just because you do your own stock picking doesn't mean you can't also tap into the knowledge and experience of the fund industry's leading players. And we've done exactly that.

Of the 600+ open-end funds available for sale in the U.K. and rated by Morningstar Analysts, there are just three within the IMA's UK Equity Income sector that have earned Morningstar Analysts' top accolade of a Gold rating. Morningstar data as at end-2011 shows that Artemis Income, Invesco Perpetual Income and Jupiter Income Trust have several common top holdings.

Vodafone (VOD) and GlaxoSmithKline (GSK) are the only two companies that feature in all three funds' top five equity holdings. Morningstar analyst Allan C. Nichols points out that, even with revenues likely to remain fairly flat in Europe, Vodafone should still generate healthy free cash flow to support its growing dividend. Meanwhile, Morningstar analyst Damien Conover notes that Glaxo generates about £6 billion in operating cash flow annually and closed 2010 with just under £6 billion in cash, putting it on solid financial ground. However, while Vodafone is currently has a 4-star rating, suggesting the shares are slightly undervalued at present, Glaxo only has a 3-star Morningstar rating, which implies that the stock is fairly valued by the market.

Among other top-five holdings, managers Adrian Frost and Adrian Gosden at Artemis Income also hold Royal Dutch Shell (RDSB) (currently rated 4 stars), BP (BP.) (3 stars) and BT Group (BT.A) (rated 2 stars).

At Invesco, Neil Woodford has been at the help of IP Income since 1990. A contrarian with a long-term view, Woodford holds AstraZeneca (AZN) (4 stars) and British American Tobacco (BATS) (2 stars) in addition to Vodafone and Glaxo, as well as a top-five holding of U.S. tobacco producer Reynolds American (RAI) (2 stars).

Over at Jupiter, manager Anthony Nutt has been running Income Trust since 2000. His list of top five holdings also features Royal Dutch Shell, AstraZeneca and BP.

Click here to learn more about the Morningstar Star Rating for stocks. To read the Morningstar Research for the above-mentioned stocks, please sign into Premium or take a free 14-day trial.

The information contained within is for educational and informational purposes ONLY. It is not intended nor should it be considered an invitation or inducement to buy or sell a security or securities noted within nor should it be viewed as a communication intended to persuade or incite you to buy or sell security or securities noted within. Any commentary provided is the opinion of the author and should not be considered a personalised recommendation. The information contained within should not be a person's sole basis for making an investment decision. Please contact your financial professional before making an investment decision.

Facebook Twitter LinkedIn

About Author

Holly Cook

Holly Cook  is Manager, Morningstar EMEA Websites

© Copyright 2024 Morningstar, Inc. All rights reserved.

Terms of Use        Privacy Policy        Modern Slavery Statement        Cookie Settings        Disclosures